期刊文献+

瑞舒伐他汀对老年CHD患者LVE和EDD的疗效 被引量:2

The clinical efficiency of rosuvastatin on LVF and EDF in elderly patients with CHD
下载PDF
导出
摘要 目的探讨瑞舒伐他汀对老年冠状动脉粥样硬化性心脏病(CHD)患者左心室功能(LVE)和内皮舒张功能(EDD)的临床疗效。方法随机抽取合阳县医院收治的心功能不全伴不稳定心绞痛老年患者160例进行回顾性分析,根据降血脂药物的选择不同分为2组,即常规组和瑞舒伐他汀组,在治疗前、治疗后3 d、1周、1个月、3个月、6个月测定患者的2组患者左心室射血分数(LVEF)、左心室高峰充盈率(LVPFR)、内皮依赖性舒张功能(EDD)、非内皮依赖性舒张功能(NEDD)。结果 2组患者治疗后左心室功能比较显示,瑞舒伐他汀组在治疗后1个月、3个月、6个月的LVEF、LVPFR大于常规组,并且治疗后1个月、3个月、6个月的LVEF、LVPFR大于治疗前,差异均有统计学意义(P<0.05)。2组患者治疗后血管内皮功能比较显示,瑞舒伐他汀组在治疗后1个月、3个月、6个月的EDD、NEDD大于常规组,并且治疗后1个月、3个月、6个月的EDD、NEDD大于治疗前,差异均有统计学意义(P<0.05)。LVEF和EDD、NEDD的Pearson相关性显示,LVEF和EDD、NEDD呈正相关(r=0.741、0.736,P=0.036、0.014)。结论瑞舒伐他汀对老年CHD患者LVE和EDD有一定改善作用。 Objective To observe the therapeutic effects of rosuvastatin on left ventricular function( LVF) and endothelium diastolic function( EDF) in elderly patients with coronary heart disease( CHD). Methods One hundred and sixty patients with cardiac insufficiency complicated by unstable angina who were treated in Heyang County Hospital were enrolled in the study. According to different antilipemic agents,the patients were divided into conventional therapy group and rosuvastatin group. The left ventricular ejection fraction( LVEF),left ventricular peak filling rate( LVPFR),endotheliumdependent diastolic function( EDD),non-endothelium-dependent diastolic function( NEDD) were detected before treatment,on 3d,1w,1m,3m,6m after treatment for both groups. Results The LVEF and LVPFR in rosuvastatin group on 1m,3m,6m after treatment were significantly higher than those in conventional therapy group,moreover,which were significantly higher than those before treatment( P 0. 05). The EDD and NEDD in rosuvastatin group on 1m,3m,6m after treatment were significantly better than those in conventional therapy group,moreover,which were significantly better than those before treatment( P 0. 05). Pearson correlation analysis showed that LVEF was positively correlated to EDD,NEDD( r = 0. 741,0. 736,respectively,P 0. 05). Conclusion Rosuvastatin can improve LVF and EDF of elderly patients with CHD at some extent.
出处 《河北医药》 CAS 2016年第17期2586-2588,共3页 Hebei Medical Journal
基金 浙江省医药卫生科技计划项目(编号:2014KYA221)
关键词 瑞舒伐他汀 冠状动脉粥样硬化 左心室功能 内皮舒张功能 rosuvastatin coronary atherosclerosis left ventricular function endothelial diastolic function
  • 相关文献

参考文献13

二级参考文献59

  • 1沈绍功,姚金城.中医心病之心绞痛诊断与疗效标准[J].中国医药学报,2004,19(10):581-583. 被引量:125
  • 2丁锦希.美国药品专利期延长制度浅析——Hatch-Waxman法案对我国医药工业的启示[J].中国医药工业杂志,2006,37(9). 被引量:23
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5222
  • 4陈可冀.心脑血管疾病研究[M].上海:上海科技出版社,1998,316?..
  • 5叶任高.内科学[M].北京:人民卫生出版社,2005.726.
  • 6中国药典委员会.中华人民共和国药典(一部)[S].北京:化学工业出版社,2005:152~153.
  • 7中国中西医结合学会心血管病专业委员会.冠心病中医辨证标准[J].中西医结合杂志,1991,11(5):257-258.
  • 8刘臻博.丹参对大鼠脊髓缺血再灌注损伤的影响[D].成都:成都中医药大学,2012.
  • 9Cai X, Li X, Li L, et al. Adiponectin reduces carotid atherosclerotic plaque formation in ApoE -/- mice:roles of oxidative and nitrosative stress and inducible nitric oxide synthase [ J]. Mol Med Rep,2015, 11(3) :1715-1721.
  • 10Kim W, Hong M J, Woo JS, et al. Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertension [ J ]. Chonnam Med J, 2013,49 ( 1 ) : 31-37.

共引文献77

同被引文献20

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部